ACTA1 and Hepatic fibrosis: In these studies we found that treating mice, administered CCl4 for 2 weeks with ISO-COOH alone failed to protect against development of liver fibrosis as measured by assessing the liver content of αSMA and Col1α1 mRNAs (Supplementary Figure 3).